Ravenquest Biomed Inc. — Form D
Ravenquest Biomed Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2018-09-10. The offering totals $8.5M, of which $327K was reported sold. Industry: Other.
Offering
- Filed: 2018-09-10
- Form: D
- Accession: 0001719252-18-000004
- Industry: Other
- Exemptions: 06b
- Total offering: $8.5M
- Amount sold: $327K
- Remaining: $8.1M
- Investors: 4
- Date of first sale: 2018-07-13
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-320971
Issuer
- Name: Ravenquest Biomed Inc.
- CIK: 0001719252
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Address: SUITE 780 - 580 HORNBY STREET, VANCOUVER, A1, V6C 3B6
- Phone: (604) 638-3886
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| David Cross | Executive Officer | VANCOUVER, A1 |
| David Cross | Related Person | VANCOUVER, A1 |
| Marla Ritchie | Executive Officer | VANCOUVER, A1 |
| Marla Ritchie | Related Person | VANCOUVER, A1 |
| Hendrik van Alphen | Related Person | VANCOUVER, A1 |
| David J Cross | Executive Officer | Vancouver, A1 |
| Anton Drescher | Director | Vancouver, A1 |
| Henk van Alphen | Director | Vancouver, A1 |
| JORGE J BONET | Director | VANCOUVER, A1 |
| CHRIS J BETCHEL | Director | VANCOUVER, A1 |
| MARLA J RITCHIE | Executive Officer | VANCOUVER, A1 |
| GEORGE ROBINSON | Director | VANCOUVER, A1 |
| GEORGE ROBINSON | Executive Officer | VANCOUVER, A1 |
| GEORGE ROBINSON | Related Person | VANCOUVER, A1 |
| HENDRIK J VAN ALPHEN | Director | VANCOUVER, A1 |
| Chris Bechtel | Director | Boulder, CO |
| Jorge Bonet | Director | VANCOUVER, A1 |
| Jorge Bonet | Related Person | VANCOUVER, A1 |
| Anton J Drescher | Director | Vancouver, A1 |
| Anton J. Drescher | Related Person | VANCOUVER, A1 |
| CHRIS BETCHEL | Related Person | VANCOUVER, A1 |
Other filings by this issuer (3)
More